Defining the Impact of Per/Polyfluoroalkyl Substance Exposure on Susceptibility to SARS-CoV-2 Infection and Disease
确定全氟烷基/多氟烷基物质暴露对 SARS-CoV-2 感染和疾病易感性的影响
基本信息
- 批准号:10362610
- 负责人:
- 金额:$ 20.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-02 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVACE2AcidsAcute Respiratory Distress SyndromeAddressAgonistAirAmericanAntibodiesAntibody titer measurementApoptosisBindingBiologicalBody BurdenCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCOVID-19COVID-19 severityCardiovascular DiseasesCell physiologyCellsChemicalsCoronavirusDataDependovirusDetectionDevelopmentDiabetes MellitusDietDiseaseDustEnvironmentEpithelial CellsEvolutionExposure toFire - disastersFoodFood ContaminationGenerationsGenetic TranscriptionHumanHypertensionImmune responseImmune systemImmunosuppressionImmunosuppressive AgentsInfectionInflammatoryInflammatory ResponseInterferon Type IIK-18 conjugateLower respiratory tract structureLymphopeniaMediatingMetabolicMetabolic DiseasesMetabolic dysfunctionModelingModernizationMusNuclear ReceptorsPPAR alphaPaintPatientsPersonsPneumoniaPolishesPoly-fluoroalkyl substancesPredispositionProductionPrognosisPropionic AcidsProteinsResolutionResourcesRiskRisk FactorsRodent ModelRoleSARS-CoV-2 infectionSeverity of illnessStainsT-LymphocyteTestingTextilesTransgenic MiceUnited StatesVaccinationVirusWaterWaxesWorkairway epitheliumalveolar epitheliumcomorbidityconstitutive androstane receptorconsumer productcoronavirus diseasecostcytokinecytokine release syndromedrinking waterenvironmental chemicalexperiencefightinghumanized mouseimmune functionin vivomacrophagemalemouse modelnovelpandemic diseaseperfluorooctanoic acidpregnane X receptorprogramsreceptorrisk minimizationsevere COVID-19sexsmall hairpin RNA
项目摘要
Project Summary
We are in the midst of an unprecedented, modern pandemic as a result of the evolution of the novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019. SARS-CoV-2 is one of three known
coronaviruses that can replicate in the lower respiratory tract and cause pneumonia and acute respiratory
distress syndrome, which can be fatal. However, people are not equally susceptible to development of severe
SARS-CoV-2 infection disease (COVID-19). Some risk factors are known, including male sex and
comorbidities related to metabolic disease. This pandemic has occurred during an endemic exposure to a
class of chemicals called per- and polyfluoroalkyl substances (PFAS) in the United States. Daily exposures
occur via PFAS contaminated food, drinking water, dust and air, resulting in nearly universal detection in
people examined. What we do not know is how PFAS exposure may influence susceptibility to SARS-CoV-2
infection and COVID-19. SARS-CoV-2 infects airway epithelial cells, triggering a Th1-polarizing pro-
inflammatory response. Resolution of the infection is driven by CD8+ T cell-mediated clearance of infected cells
and inactivation of the free virus by antibody-binding. Disease severity is associated with lymphopenia and
reduced IFN-γ production by CD4+ T cells. PFAS are well-known immunosuppressive agents in rodent models,
and PFAS are associated with reduced antibody titers following vaccinations in humans. Our data, and others,
show that PFAS are agonists for nuclear receptors, including peroxisome proliferator activated receptor α
(PPARα), constitutive androstane receptor (CAR) and pregnane X receptor (PXR) and that their respective
transcriptional programs are upregulated following in vivo exposure. Intriguingly, activation of at least PPARα
and PXR in T cells results in Th2-skewing, reduced IFN-γ production, and lymphopenia. Here, we propose to
examine the interaction between exposure to legacy (perfluorooctanoic acid, PFOA) and replacement
(perfluoro(2-methyl-3-oxahexanoic) acid, GenX) PFAS and infection with SARS-CoV-2. We will test the
hypothesis that PFAS exposure enhances susceptibility to SARS-CoV-2 infection via interaction with nuclear
receptors. First, there are critical, species-specific differences in proteins regulating susceptibility to SARS-
CoV-2 infection (angiotensin-converting enzyme 2 (ACE2)) and the biological effects of PFAS (PPARα). In Aim
1 we will generate a novel hACE2/hPPARα transgenic mouse and examine the effects of SARS-CoV-2
infection in mice with human relevant steady-state body burdens of PFAS. Second, efficient CD4+ T cell
function is essential for minimizing risk of developing COVID-19. PFAS activate multiple nuclear receptors
known to regulate immune function and T cell function. In Aim 2, we will use adeno-associated virus-mediated
transduction of PPARα, CAR and PXR shRNA in vivo, to test the necessity for each receptor in enhancing
susceptibility to SARS-CoV-2 and how PFOA’s effects are modified. The results will provide essential
information on how concurrent exposures to environmental chemicals enhance the risk of severe COVID-19.
项目摘要
由于小说的演变,我们正处于前所未有的现代大流行中
2019年急性呼吸综合征冠状病毒2(SARS-COV-2)。SARS-COV-2是已知的三个
可以在下呼吸道复制并引起肺炎和急性呼吸的冠状病毒
遇险综合征,可能是致命的。但是,人们并不容易受到严重发展
SARS-COV-2感染疾病(Covid-19)。已知一些危险因素,包括男性和
合并症与代谢疾病有关。这种大流行是在接触到A的情况下发生的
在美国,称为每类和多氟烷基物质(PFA)的化学物质类别。每日暴露
通过PFA污染的食物,饮用水,灰尘和空气发生,导致几乎普遍的检测
人们检查了。我们不知道的是PFAS暴露如何影响SARS-COV-2的易感性
感染和共同-19。 SARS-COV-2感染气道上皮细胞,触发Th1违法性
炎症反应。感染的分辨率是由CD8+ T细胞介导的感染细胞驱动的
并通过抗体结合使游离病毒失活。疾病的严重程度与淋巴细胞减少症和
CD4+ T细胞的IFN-γ降低。 PFA是啮齿动物模型中著名的免疫抑制剂,
PFA与人类接种后的抗体滴度减少有关。我们的数据以及其他
表明PFA是核接收器的激动剂,包括过氧化物体增殖物激活受体α
(PPARα),组成型雄激素受体(CAR)和孕妇X受体(PXR),其相对
在体内暴露后,转录程序上调。有趣的是,至少PPARα的激活
T细胞中的PXR和PXR导致Th2稳定,减少IFN-γ的产生和淋巴细胞减少。在这里,我们建议
检查暴露于遗产(Pertluorooctanoic,PFOA)和更换之间的相互作用
(全氟(2-甲基-3-氧气)酸,genx)PFA和SARS-COV-2感染。我们将测试
假设PFAS暴露通过与核相互作用增强对SARS-COV-2感染的敏感性
受体。首先,在调节SARS-
COV-2感染(血管紧张素转化酶2(ACE2))和PFAS(PPARα)的生物学作用。目标
1我们将生成一种新型的HACE2/HPPARα转基因小鼠并检查SARS-COV-2的影响
PFA的人类相关稳态燃烧的小鼠感染。第二,有效的CD4+ T细胞
功能对于最大程度地减少开发Covid-19的风险至关重要。 PFA激活多个核接收器
已知可以调节免疫功能和T细胞功能。在AIM 2中,我们将使用与腺相关的病毒介导的
PPARα,CAR和PXR SHRNA在体内的转导,以测试每个受体的必要条件以增强
对SARS-COV-2的敏感性以及PFOA的效果如何被修改。结果将提供必不可少的
有关以及对环境化学物质的同时暴露如何增强严重共同Covid-19的风险的信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Florian Douam其他文献
Florian Douam的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Florian Douam', 18)}}的其他基金
Characterization of a human-specific positive regulator of flavivirus infection
黄病毒感染的人类特异性正调节因子的表征
- 批准号:
9721324 - 财政年份:2021
- 资助金额:
$ 20.17万 - 项目类别:
Characterization of a human-specific positive regulator of flavivirus infection
黄病毒感染的人类特异性正调节因子的表征
- 批准号:
10843473 - 财政年份:2021
- 资助金额:
$ 20.17万 - 项目类别:
Defining the Impact of Per/Polyfluoroalkyl Substance Exposure on Susceptibility to SARS-CoV-2 Infection and Disease
确定全氟烷基/多氟烷基物质暴露对 SARS-CoV-2 感染和疾病易感性的影响
- 批准号:
10193236 - 财政年份:2021
- 资助金额:
$ 20.17万 - 项目类别:
Characterization of a human-specific positive regulator of flavivirus infection
黄病毒感染的人类特异性正调节因子的表征
- 批准号:
10381448 - 财政年份:2021
- 资助金额:
$ 20.17万 - 项目类别:
相似国自然基金
CAFs来源的外泌体负性调控ACE2促进肾透明细胞癌癌栓新辅助靶向耐药的机制研究
- 批准号:82373169
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
人类ACE2变构抑制剂的成药性及其抗广谱冠状病毒感染的机制研究
- 批准号:82330111
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
新型蝙蝠MERS簇冠状病毒HKU5的ACE2受体识别及细胞入侵机制研究
- 批准号:32300137
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于AT2/ACE2/Ang(1-7)/MAS轴调控心脏-血管-血液系统性重构演变规律研究心衰气虚血瘀证及其益气通脉活血化瘀治法生物学基础
- 批准号:82305216
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于外泌体miRNAs介导细胞通讯的大豆ACE2激活肽调控血管稳态机制研究
- 批准号:32302080
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Extracellular vesicles encapsulating CRISPR machinery for treatment of SARS-CoV-2 infection
封装 CRISPR 机制的细胞外囊泡用于治疗 SARS-CoV-2 感染
- 批准号:
10655147 - 财政年份:2023
- 资助金额:
$ 20.17万 - 项目类别:
Large-scale compatibility assessments between ACE2 proteins and diverse sarbecovirus spikes
ACE2 蛋白和多种 sarbecovirus 尖峰之间的大规模兼容性评估
- 批准号:
10722852 - 财政年份:2023
- 资助金额:
$ 20.17万 - 项目类别:
Structure-based computational engineering of saCas9 PAM requirement
saCas9 PAM 要求的基于结构的计算工程
- 批准号:
10696610 - 财政年份:2023
- 资助金额:
$ 20.17万 - 项目类别:
Structure-guided neutralizing antibodies developed using EpiVolve technology
使用 EpiVolve 技术开发的结构引导中和抗体
- 批准号:
10698958 - 财政年份:2023
- 资助金额:
$ 20.17万 - 项目类别:
Megakaryocyte regulation by the gut microbiome
肠道微生物组对巨核细胞的调节
- 批准号:
10720081 - 财政年份:2023
- 资助金额:
$ 20.17万 - 项目类别: